The Problem
A COA is only as trustworthy as the process behind it
Two distinct markets. Two versions of the same problem.
🧪 Peptides — Grey Market Verification Gap
The peptide market operates largely in a grey market — vendors sell research-grade compounds online and P2P without disclosing their upstream supplier. COAs travel as static PDFs with no way to verify authenticity. A buyer cannot confirm the document is real, untampered, or applies to the specific lot they received.
Grey market anonymity means supplier disclosure is neither expected nor required — creating a verification vacuum
COA forgery — copying or altering a legitimate PDF from another batch
Dilution fraud — substituting lower-purity product after a clean test
💊 Nutraceuticals — Certified Ingredient Fraud
In the regulated nutraceutical market, label fraud is endemic. Brands claim premium certified ingredients — KSM-66 ashwagandha, Albion magnesium, Bioperine — while delivering cheaper generic substitutes. Retailers and consumers have no independent mechanism to verify that the finished product actually contains the certified ingredient at the stated dose.
Certified ingredient substitution — generic actives sold under branded ingredient names
Under-dosing — correct ingredient, wrong potency, label claim unverified
No independent verification layer for certified ingredient claims in supplements or peptides
The Solution
Lab-anchored blockchain: the COA becomes a verifiable record, not a document
When Cert Biohealth completes a test, results are written to the blockchain — cryptographically signed by the lab's accredited identity — and linked to a QR code on the physical product or listing. One solution. Both markets.
🧪 Peptides — Verified Without Exposure
Supplier identity stays private — chain starts at the lab, fully compatible with grey market anonymity requirements
Any buyer scans and instantly verifies: lab name, test date, purity result, lot number — no login required
Records are immutable — no vendor can forge, alter, or misattribute a COA after the fact
💊 Nutraceuticals — Certified Ingredient Confirmed
Cert Biohealth tests the finished product and confirms the certified ingredient is present at the labelled dose
Result anchored on-chain — retailer or consumer scans QR and sees independent verification instantly
Premium brands finally have proof to match their claims — a meaningful competitive differentiator
How It Works — The Three-Party Chain
1
Sample Submitted
Vendor submits peptide or nutraceutical batch to Cert Biohealth. Supplier identity not required.
2
Lab Tests & Anchors
HPLC, MS, ICP-MS results written to blockchain, signed by Cert Biohealth's accredited lab identity.
3
QR Code Issued
Lot-specific QR generated and linked to the immutable on-chain record. Applied to product or listing.
4
Buyer Verifies
Any buyer scans the QR. No login required. Full test results displayed in real time from the chain.
Competitive Advantage — Why BTHBiohealth is Structurally Different
| Platform |
Model |
Lab Controls Chain? |
Canada / CPRA? |
Peptides + Nutra? |
Authentichain
US · Peptide Authentication · NFC Tags |
A product authentication service used by peptide vendor PeptivaLabs. NFC chips are embedded in packaging by the vendor — the vendor controls the blockchain record, not an independent lab. Buyers verify the tag is genuine, but cannot verify the product inside matches the COA.
⚠ The ProblemThe vendor writes to the blockchain — not the lab. A diluted or misrepresented product can carry a legitimate Authentichain tag. The tag proves the package wasn't cloned. It does not prove what's inside.
✓ BTH AdvantageCert Biohealth writes the test result directly to the chain. The vendor never touches it. The blockchain record IS the COA — issued by the accredited lab, not the seller.
|
✗ Vendor-controlled |
✗ US only |
⚬ Peptides only |
HealthLOQ
US · Nutraceutical Blockchain · SaaS Platform |
A US-based SaaS platform that allows nutraceutical brands and labs to anchor COA data to a blockchain. Both the lab and brand sign up as separate users — the platform is a neutral third party, not the lab itself. Trust depends on the platform operator, not the accredited lab.
⚠ The ProblemLabs and brands are both just users of a third-party platform. The SaaS operator controls the infrastructure. There's no structural guarantee the entity writing a record is the one that ran the test.
✓ BTH AdvantageNo middleman platform. Cert Biohealth IS the operator — write access belongs exclusively to the accredited lab. Structurally unforgeable by design, not by policy.
|
✗ Third-party SaaS |
✗ US only |
⚬ Nutra only |
Wholechain / Tilkal
US / EU · Food & Agriculture Supply Chain |
Enterprise blockchain traceability platforms built for food, seafood, and agriculture supply chains. Wholechain operates primarily in the US; Tilkal in the EU. Neither platform supports pharma-grade COA verification, peptide testing, or the Canadian nutraceutical market.
⚠ The ProblemBuilt to trace where a fish came from — not to verify peptide purity or certified ingredient identity. No COA anchoring, no pharma-grade lab integration, no relevance to the peptide or supplement market.
✓ BTH AdvantageBTHBiohealth is purpose-built for peptide and nutraceutical COA verification — integrated with an ISO/IEC 17025 accredited Canadian lab, CPRA-aligned, and designed for the grey market and NHP frameworks.
|
✗ Third-party SaaS |
✗ Not Canada-focused |
✗ Neither market |
BTHBiohealth
Canada · Peptides & Nutraceuticals · Lab-Operated |
The accredited lab IS the blockchain operator. Only Cert Biohealth can write a verified record. Structurally unforgeable. |
✓ Lab-controlled |
✓ Canada · CPRA |
✓ Both markets |
Market Opportunity & Revenue Model
Two Addressable Markets
$3.2B+
Global research peptide market · Growing 12% annually
$500B+
Global nutraceutical market · Health Canada NHP regulated
Canada's peptide research market operates under the Health Canada research exemption framework, with CPRA providing independent vendor certification — a requirement that already mandates ISO-accredited COAs. The nutraceutical market is fully regulated under Health Canada's NHP framework. BTHBiohealth serves both markets today, with no regulatory dependency required.
Revenue Streams — No Government Dependency
🔗
Per-COA Blockchain Anchoring
Premium fee on every Cert Biohealth test that produces an on-chain record + QR. Scales with lab testing volume.
📊
Vendor Portal Subscriptions
Monthly/annual access to BTHBiohealth dashboard: product management, QR hosting, scan analytics, compliance exports.
🔌
Institutional API Access
Pharmacies, online marketplaces, and retailers query lot numbers for real-time verification before accepting product.
Capital Deployed to Date — Blockchain Technology House (BTH)
$80K
Blockchain Architecture & Technology Development
Protocol selection, smart contract R&D, API architecture for lab LIMS integration, QR/barcode verification infrastructure, and platform backend development. Technology in active development with in-house expertise.
$50K
CPNSA Framework Creation & Government Relations
Drafting of the Canadian Peptide & Nutraceutical Standards Authority mandate, governance structure, certification framework, and vendor registry model. Lobbyist engagement and regulatory consultation with Health Canada alignment. BTH owns the framework.
$35K
Legal, IP & Corporate Structure
Incorporation of Blockchain Technology House (BTH), provisional patent filings on the lab-anchored COA verification method, partnership framework agreements, and data ownership legal architecture.
$30K
Platform & Product Design
UX and UI design for the BTHBiohealth platform, client verification portal, vendor dashboard, brand identity, and the scan-to-verify consumer experience. Website and portal in development.
$20K
Market Research & Competitive Intelligence
Competitive landscape analysis across Authentichain, HealthLOQ, Wholechain, and Tilkal. Market sizing across peptide and nutraceutical segments. Validation with industry participants and CPRA.
$10K
CPRA Collaboration & CPNSA Action Plan Development
Collaborative engagement with the
Canadian Peptide Research Alliance (CPRA) ↗ to develop the advanced CPNSA concept, interface strategy, and government action plan — designed to build upon and ultimately secure government authorization for the creation of the CPNSA as a formally recognized regulatory body.
$25K
Retained
Strategic Advisory
BTH retained
Domino Equity Partners — a Toronto-based merchant bank specializing in
financial advisory and pre-IPO positioning services — to coordinate the development of the Cert Biohealth investment deck, business plan, and certbiohealth.ca website. Domino provides corporate consulting, strategic planning, and capital market advisory as BTH prepares Cert Biohealth for institutional engagement and a structured liquidity event. 120 Adelaide Street West, Suite 2500, Toronto · 416 363 1433.
BTH deployed CAD $250K to build BTHBiohealth — the blockchain verification platform. The current raise funds the Cert Biohealth lab buildout — the revenue-generating engine of the BTH ecosystem. Lab revenues begin once construction and accreditation are complete. The business model does not depend on CPNSA ratification or government action.
⚖ Parallel Government Track
A government-backed evolution of
CPRA ↗ — the
Canadian Peptide & Nutraceutical Standards Authority (CPNSA) — is being pursued in parallel through regulatory engagement. BTHBiohealth is designed as the natural infrastructure for any future federal framework, positioning it as the existing platform a mandate would adopt rather than build.
The business model does not depend on this outcome.